Evidence map›Paper›PMID 40919550›Full record

ArticlePalliative medicine reports2025

A Feasibility Randomized Controlled Trial of Nurse-Led Screening-Based Early Care Program from the Time of Diagnosis for Patients with Advanced Lung Cancer and Their Caregivers.

Takashi Sato, Hiroya Manaka, Miyuki Kodama, Rina Nieda, Yasumi Kawamura, Mina Yamamoto, Yasuko Genkai, Yumiko Kezuka, Atsuko Watanabe, Nobuki Kaizuka and 9 more

Abstract read
In one paragraph

Article in Palliative medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Takashi SatoDepartment of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.ORCID https://orcid.org/0000-0002-2338-1665
Hiroya ManakaDepartment of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Miyuki KodamaDepartment of Nursing, Kitasato University Hospital, Sagamihara, Japan.
Rina NiedaDepartment of Nursing, Kitasato University Hospital, Sagamihara, Japan.
Yasumi KawamuraDepartment of Nursing, Kitasato University Hospital, Sagamihara, Japan.
Mina YamamotoDepartment of Nursing, Kitasato University Hospital, Sagamihara, Japan.
Yasuko GenkaiDepartment of Nursing, Kitasato University Hospital, Sagamihara, Japan.
Yumiko KezukaDepartment of Nursing, Kitasato University Hospital, Sagamihara, Japan.
Atsuko WatanabeDepartment of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Nobuki KaizukaDepartment of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Hiroki ItoDepartment of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Hideyuki SoneDepartment of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Masayuki ShirasawaDepartment of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Seiichiro KusuharaDepartment of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Mikiko KakegawaDepartment of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Yoshiro NakaharaDepartment of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Daisuke FujisawaDivision of Patient Safety, Keio University School of Medicine, Tokyo, Japan.
Jiichiro SasakiResearch and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan.
Katsuhiko NaokiDepartment of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although early palliative care (EPC) integrated into standard cancer care improves the quality of lives of patients with cancer and their caregivers, implementation strategies for EPC programs in individual clinical settings have not been established. Objective: This pilot randomized controlled trial explored the feasibility, acceptability, and effectiveness of nurse-led EPC using a screening-based program that focused on the individual concerns of patients with advanced lung cancer and their caregivers. Design: This pilot study was a parallel-group randomized controlled trial in which patients were randomly assigned (1:1) to receive either EPC using the care program or standard care alone. Setting/Subjects: At one university hospital in Japan, 32 patients with newly diagnosed stage IV lung cancer and their 27 caregivers participated. Measurements: Feasibility was evaluated using recruitment and interview execution rates. Acceptability and effectiveness of the care program were also evaluated. Results: The recruitment rate was 91%. The interview execution rates were 14/14 (100%) at baseline, 11/14 (79%) at 1 month, and 12/14 (86%) at 3 months for patients, and 10/11 (91%) at baseline, 6/11 (55%) at 1 month, and 7/11 (64%) at 3 months for caregivers. At 5 months, 55% of patients in the intervention group responded that the delivered care was valuable, while 88% of caregivers in the same group answered that it was valuable. The prevalence of severe concerns in patients and caregivers in the intervention group decreased after 1 month. Conclusions: This pilot randomized controlled trial revealed that EPC using a screening-based program that focused on individual concerns in patients with advanced lung cancer and their caregivers was feasible and acceptable.

Indexed as

advanced cancerearly palliative carefamily caregiverfeasibilitylung cancerrandomized controlled trial

Identifiers

PMID40919550
PMCPMC12412390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.